{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T06:42:10Z","timestamp":1789540930375,"version":"build-2803163510"},"reference-count":52,"publisher":"Walter de Gruyter GmbH","issue":"2","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,6,8]]},"abstract":"<jats:title>Summary<\/jats:title>\n                  <jats:p>\n                    This study aimed to determine the effectiveness of mefl oquine alone or combined with albendazole in reduced doses against\n                    <jats:italic>T. spiralis<\/jats:italic>\n                    infection. One hundred and twenty albino mice were orally infected with 200\n                    <jats:italic>T. spiralis<\/jats:italic>\n                    larvae\/mouse. Drugs were administered during the enteral phase on days 1 to 3 and on the chronic phase on days 35 to 37 post-infection, and mice were sacrificed, respectively, at days 7 or 48 post-infection to count mature intestinal worms or encysted muscle larvae. The effect of the treatment on the histology of the target organs of each phase, intestine and diaphragm, was also evaluated. A signifi cant decrease in intestinal worms was found in all treated groups relative to the untreated control group at a peak of 93.7% in the combination albendazole-mefl oquine group. Results in all treated groups demonstrated a signifi cant decrease in muscle larvae relative to untreated control groups, achieving 86.2 % in the combined albendazole-mefl oquine group. There was a marked improvement in the intestinal and muscular architecture in all treated groups compared to the non-treated control group. Notably, the albendazole-mefl oquine group showed an almost complete recovery. The combined albendazole-mefl oquine low dose regimen had the highest effect on reducing parasite burden and restoring normal histological architecture.\n                  <\/jats:p>","DOI":"10.2478\/helm-2021-0016","type":"journal-article","created":{"date-parts":[[2021,6,8]],"date-time":"2021-06-08T00:42:26Z","timestamp":1623112946000},"page":"179-187","source":"Crossref","is-referenced-by-count":18,"title":["Therapeutic efficacy of Albendazole and Mefloquine alone or in combination against early and late stages of\n                    <i>Trichinella spiralis<\/i>\n                    infection in mice"],"prefix":"10.2478","volume":"58","author":[{"given":"A. M.","family":"Fahmy","sequence":"first","affiliation":[{"name":"Department of Immunology and Drug Evaluation, Theodor Bilharz Research Institute, Imbaba , Giza , Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T. M.","family":"Diab","sequence":"additional","affiliation":[{"name":"Department of Immunology and Drug Evaluation, Theodor Bilharz Research Institute, Imbaba , Giza , Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"374","published-online":{"date-parts":[[2021,6,8]]},"reference":[{"key":"2026042808563099883_j_helm-2021-0016_ref_001","unstructured":"ABDEL-FATTAH, N.S., AHMED, N.S. (2011): Evaluation of mefloquine-praziquantel combination therapy in pre-patent and patent Schistosoma mansoni infection in mice. Sci Parasitol, 12(3):139\u2013149"},{"key":"2026042808563099883_j_helm-2021-0016_ref_002","doi-asserted-by":"crossref","unstructured":"ABDEL-HAFEEZ, E., KAMAL, A., ABDELGELIL, N., ABDEL-FATAH, M. (2015): Parasites transmitted to human by ingestion of different types of meat, El-Minia City, El-Minia Governorate, Egypt. J Egypt Soc Parasitol, 45(3): 671\u2013680. DOI: 10.12816\/0017935","DOI":"10.21608\/jesp.2015.97567"},{"key":"2026042808563099883_j_helm-2021-0016_ref_003","doi-asserted-by":"crossref","unstructured":"ABOU-SHADY, O.M., MOHAMMED, S.S., ATTIA, S.S., YUSUF, H.-A.S., HELMY, D.O. (2016): Therapeutic effect of mefloquine on Schistosoma mansoni in experimental infection in mice. J Parasit Dis, 40(2): 259\u2013267. DOI: 10.1007\/s12639-014-0489-4","DOI":"10.1007\/s12639-014-0489-4"},{"key":"2026042808563099883_j_helm-2021-0016_ref_004","doi-asserted-by":"crossref","unstructured":"ABOU RAYIA, D.M., SAD, A.E., ASHOUR, D.S., OREIBY, R.M. (2017): Implication of artemisinin nematocidal activity on experimental trichinellosis: In vitro and in vivo studies. Parasitol Int, 66(2): 56\u201363. DOI: 10.1016\/j.parint.2016.11.012","DOI":"10.1016\/j.parint.2016.11.012"},{"key":"2026042808563099883_j_helm-2021-0016_ref_005","doi-asserted-by":"crossref","unstructured":"AKIHO, H., DENG, Y., BLENERHASETT, P., KANBAYASHI, H., COLLINS, S.M. (2005): Mechanisms underlying the maintenance of muscle hyper contractility in a model of post-infective gut dysfunction. Gastroenterology, 129(1): 131\u2013141. DOI: 10.1053\/j.gastro.2005.03.049 ALY, N., SELEM, R., ZALAT, R., KHALIL, H., TALHA, B. (2017): An innovative repurposing of mefloquine; assessment of its therapeutic efficacy in treating Cryptosporidium parvum infection of both immunocompetent and immunocompromised mice. J Egypt Soc Parasitol, 47(2): 253\u2013262. DOI: 10.12816\/JESP.2017.77763","DOI":"10.21608\/jesp.2017.77763"},{"key":"2026042808563099883_j_helm-2021-0016_ref_006","doi-asserted-by":"crossref","unstructured":"ANDREWS, K.T., FISHER, G., SKINER-ADAMS, T.S. (2014): Drug repurposing and human parasitic protozoan diseases. Int J Parasitol Drugs Drug Resist, 4(2): 95\u2013111. DOI: 10.1016\/j.ijpddr.2014.02.002","DOI":"10.1016\/j.ijpddr.2014.02.002"},{"key":"2026042808563099883_j_helm-2021-0016_ref_007","doi-asserted-by":"crossref","unstructured":"ATTIA, R., MAHMOUD, A., FARAG, H., MAKBOUL, R., MOHAMED, M., IBRAHEIM, Z. (2015): Effect of myrrh and thyme on Trichinella spiralis enteral and parenteral phases with inducible nitric oxide expression in mice. Mem Inst Oswaldo Cruz, 110(8): 1035\u20131041. DOI: 10.1590\/0074-02760150295","DOI":"10.1590\/0074-02760150295"},{"key":"2026042808563099883_j_helm-2021-0016_ref_008","doi-asserted-by":"crossref","unstructured":"BAI, X., HU, X., LIU, X., TANG, B., LIU, M. (2017): Current research of trichinellosis in China. Front Microbiol, 8: 1\u20137. DOI: 10.3389\/fmicb.2017.01472","DOI":"10.3389\/fmicb.2017.01472"},{"key":"2026042808563099883_j_helm-2021-0016_ref_009","doi-asserted-by":"crossref","unstructured":"BALASUBRAMANIAN, A., TERAMOTO, T., KULKARNI, A.A., BHATTACHARJEE, A.K., PADMANABHAN, R. (2017): Antiviral activities of selected antimalarial against dengue virus type 2 and Zika virus. Antiviral Res, 137, 141\u2013150. DOI: 10.1016\/j.antiviral.2016.11.015","DOI":"10.1016\/j.antiviral.2016.11.015"},{"key":"2026042808563099883_j_helm-2021-0016_ref_010","doi-asserted-by":"crossref","unstructured":"BARNES, E.H., DOBSON, R.J., BARGER, I.A. (1995): Worm control and anthelmintic resistance: adventures with a model. In Parasitology Today (Vol. 11, Issue 2, pp. 56\u201363). Elsevier Current Trends. DOI: 10.1016\/0169-4758(95)80117-0","DOI":"10.1016\/0169-4758(95)80117-0"},{"key":"2026042808563099883_j_helm-2021-0016_ref_011","doi-asserted-by":"crossref","unstructured":"CAPO, V.A., DESPOMMIER, D.D., POLVERE, R.I. (1998): Trichinella spiralis: vascular endothelial growth factor is up-regulated within the nurse cell during the early phase of its formation. J Parasitol, 84(2): 209. PMID: 9576489","DOI":"10.2307\/3284472"},{"key":"2026042808563099883_j_helm-2021-0016_ref_012","doi-asserted-by":"crossref","unstructured":"CEBALLOS, L., KROLEWIECKI, A., JU\u00c1REZ, M., MORENO, L., SCHAER, F., ALVAREZ, L.I., CIMINO, R., WALSON, J., LANUSE, C.E. (2018): Assessment of serum pharmacokinetics and urinary excretion of albendazole and its metabolites in human volunteers. PLoS Negl Trop Dis, 12(1): e0005945. DOI:10.1371\/journal.pntd.0005945","DOI":"10.1371\/journal.pntd.0005945"},{"key":"2026042808563099883_j_helm-2021-0016_ref_013","doi-asserted-by":"crossref","unstructured":"CODINA, A.V., GARC\u00cdA, A., LEONARDI, D., VASCONI, M.D., DIMASO, R.J., LAMAS, M.C., HINRICHSEN, L.I. (2015): Efficacy of albendazole:\u03b2-cyclodextrin citrate in the parenteral stage of Trichinella spiralis infection. Int J Biol Macromol, 77, 203\u2013206. DOI: 10.1016\/j.ijbiomac.2015.02.049","DOI":"10.1016\/j.ijbiomac.2015.02.049"},{"key":"2026042808563099883_j_helm-2021-0016_ref_014","doi-asserted-by":"crossref","unstructured":"DAYAN, A.D. (2003): Albendazole, mebendazole and praziquantel. Review of non-clinical toxicity and pharmacokinetics. Acta Trop, 86(2\u20133): 141\u2013159. DOI: 10.1016\/S0001-706X(03)00031-7","DOI":"10.1016\/S0001-706X(03)00031-7"},{"key":"2026042808563099883_j_helm-2021-0016_ref_015","doi-asserted-by":"crossref","unstructured":"DUN, I.J., WRIGHT, K.A. (1985): Cell injury caused by Trichinella spiralis in the mucosal epithelium of B10A mice. J Parasitol, 71(6): 757\u2013766. DOI: 10.2307\/3281709","DOI":"10.2307\/3281709"},{"key":"2026042808563099883_j_helm-2021-0016_ref_016","doi-asserted-by":"crossref","unstructured":"DYAB, A. (2019): Prevalence and histopathology of Trichinella Spiralis larvae of slaughtered pigs in Cairo Governorate, Egypt. J Egypt Soc Parasitol, 49(2): 439\u2013442. DOI: 10.21608\/JESP.2019.68187 ELGENDY, D.I., OTHMAN, A.A., HASBY SAD, M.A., SOLIMAN, N.A., MWAFY, S.E. (2020): Resveratrol reduces oxidative damage and inflammation in mice infected with Trichinella spiralis J Helminthol, 94, e140. DOI: 10.1017\/S0022149X20000206","DOI":"10.1017\/S0022149X20000206"},{"key":"2026042808563099883_j_helm-2021-0016_ref_017","doi-asserted-by":"crossref","unstructured":"ELMEHY, D.A., ISMAIL, H.I., SOLIMAN, N.A., AMER, B.S., ELKALINY, H.H., EL-EBIARY, A.A., GAMEA, G.A. (2021): Oxidative stress mediated apoptotic potential of mefloquine on experimental trichinellosis. Acta Trop, 213, 105760. DOI: 10.1016\/j.actatropica.2020.105760","DOI":"10.1016\/j.actatropica.2020.105760"},{"key":"2026042808563099883_j_helm-2021-0016_ref_018","unstructured":"FAKAHANY, A.F., YOUNIS, M.S., EL HAMSHARY, A.M., FOUAD, M., HASAN, M., ALI, H. (2014): Effect of mefloquine on worm burden and tegumental changes in experimental Schistosoma mansoni infection. J Microsc Ultrastruct, 2(1): 7\u201311. DOI: 10.1016\/j.jmau.2014.03.001 GUTMAN, J., GREEN, M., DURAND, S., ROJAS, O.V., GANGULY, B., QUEZADA, W.M., UTZ, G.C., SLUTSKER, L., RUEBUSH, T.K., BACON, D.J. (2009): Mefloquine pharmacokinetics and mefloquine-artesunate effectiveness in Peruvian patients with uncomplicated Plasmodium falciparum malaria. Malar J, 8(1): 58. DOI: 10.1186\/14752875-8-58"},{"key":"2026042808563099883_j_helm-2021-0016_ref_019","doi-asserted-by":"crossref","unstructured":"JIANG, P., WANG, Z.-Q., CUI, J., ZHANG, X. (2012): Comparison of artificial digestion and Baermann\u2019s methods for detection of Trichinella spiralis pre-encapsulated larvae in muscles with low-level infections. Foodborne Pathog Dis, 9(1): 27\u201331. DOI: 10.1089\/fpd.2011.0985","DOI":"10.1089\/fpd.2011.0985"},{"key":"2026042808563099883_j_helm-2021-0016_ref_020","doi-asserted-by":"crossref","unstructured":"KALAISELVAN, R., MOHANTA, G.P., MADHUSUDAN, S., MANA, P.K., MANAVALAN, R. (2007): Enhancement of bioavailability and anthelmintic efficacy of albendazole by solid dispersion and cyclodextrin complexation techniques. Pharmazie, 62(8): 604\u2013607. PMID: 17867556 KAMILI, C., KAKATAPAR THY, R.S., VATTIKUTTI, U.M., CHIDRAWAR, V., AMMINENI, S. (2017): Anti-proliferative and anti-angiogenic activities of ion-channel modulators: In-ovo, in-vitro and in-vivo study. Asian Pac J Trop Biomed, 7(6): 555\u2013562. DOI: 10.1016\/j.apjtb.2017.05.005","DOI":"10.1016\/j.apjtb.2017.05.005"},{"key":"2026042808563099883_j_helm-2021-0016_ref_021","doi-asserted-by":"crossref","unstructured":"KANG, Y.-J., JO, J.-O., CHO, M.-K., YU, H.-S., OCK, M. S., CHA, H.J. (2011): Trichinella spiralis infection induces angiogenic factor thymosin \u03b24 expression. Vet Parasitol, 181(2\u20134): 222\u2013228. DOI: 10.1016\/j.vetpar.2011.03.058","DOI":"10.1016\/j.vetpar.2011.03.058"},{"key":"2026042808563099883_j_helm-2021-0016_ref_022","doi-asserted-by":"crossref","unstructured":"KEISER, J., CHOLLET, J., XIAO, S.H., MEI, J.Y., JIAO, P.Y., UTZINGER, J., TANER, M. (2009): Mefloquine-An amino alcohol with promising antischistosomal properties in mice. PLoS Negl Trop Dis, 3(1). DOI: 10.1371\/journal.pntd.0000350","DOI":"10.1371\/journal.pntd.0000350"},{"key":"2026042808563099883_j_helm-2021-0016_ref_023","doi-asserted-by":"crossref","unstructured":"KEISER, J., N\u2019GUESAN, N. A., ADOUBRYN, K. D., SILU\u00c9, K.D., VOUNATSOU, P., HATZ, C., UTZINGER, J., N\u2019GORAN, E.K. (2010): Efficacy and safety of mefloquine, artesunate, mefloquine\u2010artesunate, and praziquantel against Schistosoma haematobium : randomized, exploratory open\u2010label trial. Clin Infect Dis, 50(9): 1205\u20131213. DOI: 10.1086\/651682","DOI":"10.1086\/651682"},{"key":"2026042808563099883_j_helm-2021-0016_ref_024","doi-asserted-by":"crossref","unstructured":"KEISER, J., UTZINGER, J. (2012): Antimalarials in the treatment of schistosomiasis. Curr Pharm Des, 18(24): 3531\u20133538. PMID: 22607145","DOI":"10.2174\/138161212801327293"},{"key":"2026042808563099883_j_helm-2021-0016_ref_025","doi-asserted-by":"crossref","unstructured":"K\u00dcSTER, T., STADELMAN, B., HERMAN, C., SCHOLL, S., KEISER, J., HEMPHILL, A. (2011): In vitro and in vivo efficacies of mefloquine-based treatment against alveolar echinococcosis. Antimicrob Agents Chemother, 55(2): 713\u2013721. DOI: 10.1128\/AAC.01392-10","DOI":"10.1128\/AAC.01392-10"},{"key":"2026042808563099883_j_helm-2021-0016_ref_026","doi-asserted-by":"crossref","unstructured":"LIU, Y., CHEN, S., XUE, R., ZHAO, J., DI, M. (2016): Mefloquine effectively targets gastric cancer cells through phosphatase-dependent inhibition of PI3K\/Akt\/mTOR signaling pathway. Biochem Biophys Res Commun, 470(2): 350\u2013355. DOI: 10.1016\/j.bbrc.2016.01.046 LOOAREESUWAN, S., WHITE, N., WARELL, D., FORGO, I., DUBACH, U., RANALDER, U., SCHWARTZ, D. (1987): Studies of mefloquine bioavailability and kinetics using a stable isotope technique: a comparison of Thai patients with falciparum malaria and healthy Caucasian volunteers. Br J Clin Pharmacol, 24(1): 37\u201342. DOI: 10.1111\/j.1365-2125.1987.tb03133.x","DOI":"10.1111\/j.1365-2125.1987.tb03133.x"},{"key":"2026042808563099883_j_helm-2021-0016_ref_027","doi-asserted-by":"crossref","unstructured":"MANECK, T., HAGGENMULLER, Y., KEISER, J. (2010): Morphological effects and tegumental alterations induced by mefloquine on Schistosomula and adult flukes of Schistosoma mansoni. Parasitology, 137(1): 85\u201398. DOI: 10.1017\/S0031182009990965","DOI":"10.1017\/S0031182009990965"},{"key":"2026042808563099883_j_helm-2021-0016_ref_028","doi-asserted-by":"crossref","unstructured":"MATADAMAS-MART\u00cdNEZ, F., NOGUEDA-TORES, B., HERN\u00c1NDEZ-CAMPOS, A., HERN\u00c1NDEZ-LUIS, F., CASTILLO, R., MENDOZA, G., AMBROSIO, J.R., ANDR\u00c9S-ANTONIO, G., Y\u00c9PEZ-MULIA, L. (2013): Analysis of the effect of a 2-(trifluoromethyl)-1H-benzimidazole derivative on Trichinella spiralis muscle larvae. Vet Parasitol, 194(2\u20134): 193\u2013197. DOI: 10.1016\/j.vetpar.2013.01.054","DOI":"10.1016\/j.vetpar.2013.01.054"},{"key":"2026042808563099883_j_helm-2021-0016_ref_029","unstructured":"MORSY, T.A., IBRAHIM, B.B., HARIDY, F.M., RIFAAT, M.M. (2000) Trichinella encysted larvae in slaughtered pigs in Cairo (1995\u20131999). J Egypt Soc Parasitol, 30(3): 753\u2013760. PMID: 11198373"},{"key":"2026042808563099883_j_helm-2021-0016_ref_030","doi-asserted-by":"crossref","unstructured":"NADA, S.M., MOHAMMAD, S.M., Moad1, H.S., EL-SHAFEY, M., AL-GHANDOUR, A.M. IBRAHIM, N. (2018): Therapeutic effect of Nigella sativa and ivermectin versus albendazole on experimental trichinellosis in mice. J Egypt Soc Parasitol, 48(1): 85\u201392. DOI: 10.12816\/jesp.2018.77029","DOI":"10.21608\/jesp.2018.77029"},{"key":"2026042808563099883_j_helm-2021-0016_ref_031","doi-asserted-by":"crossref","unstructured":"NASEF, N.E., MOHARM, I.M., ATIA, A.F., BARAKAT, R.M., ABOU HUSEIN, N.M., MOHAMED, A.S. (2018): Therapeutic efficacy of chitosan nano-particles and albendazole in intestinal murine trichinellosis. J Egypt Soc Parasitol, 48(3): 493\u2013502. DOI: 10.12816\/jesp.2018.76543","DOI":"10.21608\/jesp.2018.76543"},{"key":"2026042808563099883_j_helm-2021-0016_ref_032","doi-asserted-by":"crossref","unstructured":"OTHMAN, A.A., SHOHEIB, Z.S. (2016): Detrimental effects of geldanamycin on adults and larvae of Trichinella spiralis Helminthologia, 53(2): 126\u2013132. DOI: 10.1515\/helmin-2016-0003","DOI":"10.1515\/helmin-2016-0003"},{"key":"2026042808563099883_j_helm-2021-0016_ref_033","doi-asserted-by":"crossref","unstructured":"OTHMAN, AHMAD A., ABOU RAYIA, D.M., ASHOUR, D.S., SAIED, E.M., ZINELDEEN, D.H., EL-EBIARY, A.A. (2016): Atorvastatin and metformin administration modulates experimental Trichinella spiralis infection. Parasitol Int, 65(2): 105\u2013112. DOI: 10.1016\/j.parint.2015.11.001","DOI":"10.1016\/j.parint.2015.11.001"},{"key":"2026042808563099883_j_helm-2021-0016_ref_034","doi-asserted-by":"crossref","unstructured":"PANIC, G., DUTHALER, U., SPEICH, B., KEISER, J. (2014): Repurposing drugs for the treatment and control of helminth infections. Int J Parasitol Drugs Drug Resist, 4(3): 185\u2013200. DOI: 10.1016\/j.ijpddr.2014.07.002","DOI":"10.1016\/j.ijpddr.2014.07.002"},{"key":"2026042808563099883_j_helm-2021-0016_ref_035","doi-asserted-by":"crossref","unstructured":"POZIO, E., SACHINI, D., SACHI, L., TAMBURINI, A., ALBERICI, F. (2001): Failure of mebendazole in the treatment of humans with Trichinella spiralis infection at the stage of encapsulating larvae. Clin Infect Dis, 812, 1\u20135. DOI: 10.1086\/318707","DOI":"10.1086\/318707"},{"key":"2026042808563099883_j_helm-2021-0016_ref_036","doi-asserted-by":"crossref","unstructured":"RODRIGUES-JUNIOR, V.S., VILLELA, A.D., GON\u00c7ALVES, R.S.B., ABBADI, B.L., TRINDADE, R.V., L\u00d3PEZ-GAV\u00cdN, A., TUD\u00d3, G., GONZ\u00c1LEZ-MART\u00cdN, J., BASO, L.A., DE SOUZA, M.V.N., CAMPOS, M.M., SANTOS, D.S. (2016): Mefloquine and its oxazolidine derivative compound are active against drug-resistant Mycobacterium tuberculosis strains and in a murine model of tuberculosis infection. J Antimicrob Agents, 48(2): 203\u2013207. DOI: 10.1016\/j.ijantimicag.2016.04.029","DOI":"10.1016\/j.ijantimicag.2016.04.029"},{"key":"2026042808563099883_j_helm-2021-0016_ref_037","doi-asserted-by":"crossref","unstructured":"ROMERO, M., ARTIGIANI, R., COSTA, H., OSHIMA, C.T.F., MISZPUTEN, S., FRANCO, M. (2008): Evaluation of the immunoexpression of COX1, COX-2 and p53 in Crohn\u2019s disease. Arq Gastroenterol, 45(4): 295\u2013300. DOI: 10.1590\/s0004-28032008000400007","DOI":"10.1590\/S0004-28032008000400007"},{"key":"2026042808563099883_j_helm-2021-0016_ref_038","doi-asserted-by":"crossref","unstructured":"RUFENER, R., RITLER, D., ZIELINSKI, J., DICK, L., DA SILVA, E.T., DA SILVA ARAUJO, A., JOEKEL, D.E., CZOCK, D., GOEPFERT, C., MORAES, A.M., DE SOUZA, M.V.N., M\u00dcLLER, J., MEVISSEN, M., HEMPHILL, A., LUNDSTR\u00d6M-STADELMANN, B. (2018): Activity of mefloquine and mefloquine derivatives against Echinococcus multilocularis Int J Parasitol Drugs Drug Resist, 8(2): 331\u2013340. DOI: 10.1016\/j.ijpddr.2018.06.004","DOI":"10.1016\/j.ijpddr.2018.06.004"},{"key":"2026042808563099883_j_helm-2021-0016_ref_039","doi-asserted-by":"crossref","unstructured":"SAAD, A.E., ASHOUR, D.S., ABOU RAYIA, D.M., BEDEER, A.E. (2016): Carbonic anhydrase enzyme as a potential therapeutic target for experimental trichinellosis. Parasitol Res, 115(6): 2331\u20132339. DOI: 10.1007\/s00436-016-4982-9","DOI":"10.1007\/s00436-016-4982-9"},{"key":"2026042808563099883_j_helm-2021-0016_ref_040","doi-asserted-by":"crossref","unstructured":"SANGSTER, N. (2001): Managing parasiticide resistance. Vet Parasitol, 98(1\u20133): 89\u2013109. DOI: 10.1016\/s0304-4017(01)00425-3","DOI":"10.1016\/S0304-4017(01)00425-3"},{"key":"2026042808563099883_j_helm-2021-0016_ref_041","doi-asserted-by":"crossref","unstructured":"SERNA, H., PORRAS, M., VERGARA, P. (2006): Mast cell stabilizer ketotifen [4-(1-Methyl-4-piperidylidene)-4 H -benzo[4,5]cyclohepta[1,2b]thiophen-10(9 H )-one Fumarate] prevents mucosal mast cell hyperplasia and intestinal dysmotility in experimental Trichinella spiralis inflammation in the Rat. J Pharmacol Exp Ther, 319(3): 1104\u20131111. DOI: 10.1124\/jpet.106.104620","DOI":"10.1124\/jpet.106.104620"},{"key":"2026042808563099883_j_helm-2021-0016_ref_042","doi-asserted-by":"crossref","unstructured":"SHALABY, M.A., MOGHAZY, F.M., SHALABY, H.A., NASR, S.M. (2010): Effect of methanolic extract of Balanites aegyptiaca fruits on enteral and parenteral stages of Trichinella spiralis in rats. Parasitol Res, 107(1): 17\u201325. DOI: 10.1007\/s00436-010-1827-9","DOI":"10.1007\/s00436-010-1827-9"},{"key":"2026042808563099883_j_helm-2021-0016_ref_043","doi-asserted-by":"crossref","unstructured":"SHARMA, N., THOMAS, S., GOLDEN, E.B., HOFMAN, F.M., CHEN, T.C., PETASIS, N.A., SCH\u00d6NTHAL, A.H., LOUIE, S.G. (2012): Inhibition of autophagy and induction of breast cancer cell death by mefloquine, an antimalarial agent. Cancer Lett, 326(2): 143\u2013154. DOI: 10.1016\/j.canlet.2012.07.029","DOI":"10.1016\/j.canlet.2012.07.029"},{"key":"2026042808563099883_j_helm-2021-0016_ref_044","doi-asserted-by":"crossref","unstructured":"SHOHEIB, Z.S., SHAMLOULA, M.M., ABDIN, A.A., SEGAI, O. (2006): Role Of \u03b1 - chymotrypsin and colchicine as adjuvant therapy in experimental muscular trichinellosis : parasitological, biochemical & immunohistochemical study. Egypt J Med Microbiol, 15(4): 773\u2013790 SINGH, N., YEH, P.J. (2017): Suppressive drug combinations and their potential to combat antibiotic resistance. J Antibiot, 70(11): 1033\u20131042. DOI: 10.1038\/ja.2017.102","DOI":"10.1038\/ja.2017.102"},{"key":"2026042808563099883_j_helm-2021-0016_ref_045","unstructured":"SIRIYASATIEN, P., YINGYOURD, P., NUCHPRAYOON, S. (2003): Efficacy of albendazole against early and late stage of Trichinella spiralis infection in mice. J Med Assoc Thai, 86(2): 8257 \u2013 S262. PMID: 12929998"},{"key":"2026042808563099883_j_helm-2021-0016_ref_046","doi-asserted-by":"crossref","unstructured":"VERCRUYSSE, J., SCHETTERS, T.P.M., KNOX, D.P., WILLADSEN, P., CLAEREBOUT, E. (2007): Control of parasitic disease using vaccines: an answer to drug resistance? Rev. sci. tech. Off. int. Epiz., 26(1): 105\u2013115. DOI: 10.20506\/rst.26.1.1728","DOI":"10.20506\/rst.26.1.1728"},{"key":"2026042808563099883_j_helm-2021-0016_ref_047","doi-asserted-by":"crossref","unstructured":"WALLER, P.J. (1997): Anthelmintic resistance. Vet Parasitol, 72(3\u20134): 391\u2013412. DOI: 10.1016\/S0304-4017(97)00107-6","DOI":"10.1016\/S0304-4017(97)00107-6"},{"key":"2026042808563099883_j_helm-2021-0016_ref_048","doi-asserted-by":"crossref","unstructured":"WASSOM, D.L., DOUGHERTY, D.A., DICK, T.A. (1988): Trichinella spiralis infections of inbred mice: immunologically specific responses induced by different Trichinella isolates. J Parasitol, 74(2): 283\u2013287. DOI: 10.2307\/3282457","DOI":"10.2307\/3282457"},{"key":"2026042808563099883_j_helm-2021-0016_ref_049","doi-asserted-by":"crossref","unstructured":"WONG, W., BAI, X.-C., SLEEBS, B.E., TRIGLIA, T., BROWN, A., THOMPSON, J.K., JACKSON, K.E., HANSSEN, E., MARAPANA , D.S., FERNANDEZ, I.S., RALPH, S.A., COWMAN, A.F., SCHERES, S.H. W., BAUM, J. (2017): Mefloquine targets the Plasmodium falciparum 80S ribosome to inhibit protein synthesis. Nat Microbiol, 2(6): 17031. DOI: 10.1038\/nmicrobiol.2017.31","DOI":"10.1038\/nmicrobiol.2017.31"},{"key":"2026042808563099883_j_helm-2021-0016_ref_050","doi-asserted-by":"crossref","unstructured":"WRANICZ, M.J., GUSTOWSKA, L., GABRYEL, P., KUCHARSKA, E., CABAJ, W. (1998): Trichinella spiralis: induction of the basophilic transformation of muscle cells by synchronous newborn larvae. Parasitol Res, 84(5): 403\u2013407. DOI: 10.1007\/s004360050418","DOI":"10.1007\/s004360050418"},{"key":"2026042808563099883_j_helm-2021-0016_ref_051","doi-asserted-by":"crossref","unstructured":"XIAO, S.H. (2013): Mefloquine, a new type of compound against Schistosomes and other helminths in experimental studies. Parasitol Res, 112(11): 3723\u20133740. DOI: 10.1007\/s00436-013-3559-0 YADAV, A.K., TEMJENMONGLA. (2012): Efficacy of Lasia spinosa leaf extract in treating mice infected with Trichinella spiralis Parasitol Res, 110(1): 493\u2013498. DOI: 10.1007\/s00436-011-2551-9","DOI":"10.1007\/s00436-011-2551-9"},{"key":"2026042808563099883_j_helm-2021-0016_ref_052","doi-asserted-by":"crossref","unstructured":"YOUSSEF, A.I., UGA, S. (2014): Review of parasitic zoonoses in Egypt. Trop Med Health, 42(1): 3\u201314. DOI: 10.2149\/tmh.2013-23","DOI":"10.2149\/tmh.2013-23"}],"container-title":["Helminthologia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/reference-global.com\/pdf\/10.2478\/helm-2021-0016","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T16:59:19Z","timestamp":1777395559000},"score":1,"resource":{"primary":{"URL":"https:\/\/reference-global.com\/article\/10.2478\/helm-2021-0016"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,1]]},"references-count":52,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2021,6,8]]},"published-print":{"date-parts":[[2021,6,8]]}},"alternative-id":["10.2478\/helm-2021-0016"],"URL":"https:\/\/doi.org\/10.2478\/helm-2021-0016","relation":{},"ISSN":["1336-9083"],"issn-type":[{"value":"1336-9083","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,1]]}}}